Memphasys to Start Utilization Testing of Reproductive Biotechnology Product in China

MT Newswires Live01-06

Memphasys (ASX:MEM) will start in vitro utilization testing of its Felix System in China as part of an agreement with Hong Kong-based biotech company Heranova Lifesciences HK, according to a Monday filing with the Australian bourse.

Heranova will conduct testing at Sichuan Jinxin Xinan Women & Children Hospital in Chengdu to assess the usability of the system in routine and challenging in vitro fertilization cases using 50 patient cases, with the company supplying 50 Felix cartridges and one console, the filing said.

The testing will assess the biological performance and health economic benefits of the system, according to the filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2501426779?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-06 09:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501426779","market":"sg","top_or_hot":-1,"title":"Memphasys to Start Utilization Testing of Reproductive Biotechnology Product in China","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/MEM.AU\">Memphasys</a> (ASX:MEM) will start in vitro utilization testing of its Felix System in China as part of an agreement with Hong Kong-based biotech company Heranova Lifesciences HK, according to a Monday filing with the Australian bourse.</p><p>Heranova will conduct testing at Sichuan Jinxin Xinan Women &amp; Children Hospital in Chengdu to assess the usability of the system in routine and challenging in vitro fertilization cases using 50 patient cases, with the company supplying 50 Felix cartridges and one console, the filing said.</p><p>The testing will assess the biological performance and health economic benefits of the system, according to the filing.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Memphasys to Start Utilization Testing of Reproductive Biotechnology Product in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMemphasys to Start Utilization Testing of Reproductive Biotechnology Product in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-06 09:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/MEM.AU\">Memphasys</a> (ASX:MEM) will start in vitro utilization testing of its Felix System in China as part of an agreement with Hong Kong-based biotech company Heranova Lifesciences HK, according to a Monday filing with the Australian bourse.</p><p>Heranova will conduct testing at Sichuan Jinxin Xinan Women &amp; Children Hospital in Chengdu to assess the usability of the system in routine and challenging in vitro fertilization cases using 50 patient cases, with the company supplying 50 Felix cartridges and one console, the filing said.</p><p>The testing will assess the biological performance and health economic benefits of the system, according to the filing.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MEM","symbol_name":"Matthews Emerging Markets Equity Active ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2501426779","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501426779","pubTimestamp":1736125631,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Memphasys  will start in vitro utilization testing of its Felix System in China as part of an agreement with Hong Kong-based biotech company Heranova Lifesciences HK, according to a Monday filing with the Australian bourse.Heranova will conduct testing at Sichuan Jinxin Xinan Women & Children Hospital in Chengdu to assess the usability of the system in routine and challenging in vitro fertilization cases using 50 patient cases, with the company supplying 50 Felix cartridges and one console, the filing said.The testing will assess the biological performance and health economic benefits of the system, according to the filing.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MEM":"Matthews Emerging Markets Equity Active ETF","BK7048":"生命科学工具和服务","MEM.AU":"Memphasys"},"translate_title":"Memphasys将在中国开始生殖生物技术产品的利用测试","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEM.AU":0.9,"MEM":1},"content_text":"Memphasys (ASX:MEM) will start in vitro utilization testing of its Felix System in China as part of an agreement with Hong Kong-based biotech company Heranova Lifesciences HK, according to a Monday filing with the Australian bourse.Heranova will conduct testing at Sichuan Jinxin Xinan Women & Children Hospital in Chengdu to assess the usability of the system in routine and challenging in vitro fertilization cases using 50 patient cases, with the company supplying 50 Felix cartridges and one console, the filing said.The testing will assess the biological performance and health economic benefits of the system, according to the filing.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2501426779","isCrawlerRequest":true}